Intravenous Immunoglobulin Market to Expand Strongly Driven by Rising Autoimmune Disorders and Advancements in Plasma-Derived Therapies
https://growthmarketreports.co....m/report/intravenous
The Intravenous Immunoglobulin Market refers to the global industry focused on the production and distribution of immunoglobulin therapies administered intravenously to treat immune deficiencies, autoimmune diseases, and inflammatory conditions. IVIG is a plasma-derived biological product containing antibodies that help strengthen immune response in patients with weakened or dysfunctional immune systems.